127 related articles for article (PubMed ID: 18471956)
21. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
Soricelli A; Cuocolo A; Varrone A; Discepolo A; Tedeschi E; Mainenti PP; Grivet-Fojaja MR; Covelli EM; Postiglione A; Salvatore M
J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
[TBL] [Abstract][Full Text] [Related]
22. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
[TBL] [Abstract][Full Text] [Related]
23. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
24. Influence of glioma's multidrug resistance phenotype on (99m)Tc-tetrofosmin uptake.
Alexiou GA; Goussia A; Kyritsis AP; Tsiouris S; Ntoulia A; Malamou-Mitsi V; Voulgaris S; Fotopoulos AD
Mol Imaging Biol; 2011 Apr; 13(2):348-51. PubMed ID: 20552283
[TBL] [Abstract][Full Text] [Related]
25. Baseline/postnitrate tetrofosmin SPECT for myocardial viability assessment in patients with postischemic severe left ventricular dysfunction: new evidence from MRI.
Giorgetti A; Pingitore A; Favilli B; Kusch A; Lombardi M; Marzullo P
J Nucl Med; 2005 Aug; 46(8):1285-93. PubMed ID: 16085584
[TBL] [Abstract][Full Text] [Related]
26. A trial of single photon emission computed tomography of the liver with technetium-99m tetrofosmin to detect hepatocellular carcinoma.
Ho YJ; Jeng LB; Yang MD; Kao CH; Lin CC; Lee CC
Anticancer Res; 2003; 23(2C):1743-6. PubMed ID: 12820451
[TBL] [Abstract][Full Text] [Related]
27. Extrastriatal uptake related to dopaminergic dysfunction on
Hou PN; Huang YE; Chan SH
Hell J Nucl Med; 2023; 26(3):210-214. PubMed ID: 38085837
[TBL] [Abstract][Full Text] [Related]
28. Correlation between 99mTc-HYNIC-octreotide SPECT/CT somatostatin receptor scintigraphy and pathological grading of meningioma.
Wang S; Yang W; Deng J; Zhang J; Ma F; Wang J
J Neurooncol; 2013 Jul; 113(3):519-26. PubMed ID: 23657621
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of thallium-201 SPECT in the evaluation of tumor natures in intracranial meningiomas.
Takeda T; Nakano T; Asano K; Shimamura N; Ohkuma H
Neuroradiology; 2011 Nov; 53(11):867-73. PubMed ID: 21221558
[TBL] [Abstract][Full Text] [Related]
30. Reduction in the recurrence of meningiomas by combining somatostatin receptor scintigraphy of (99m)Tc-HYNIC-octreotide SPECT/CT and radio guidance with a hand-held γ-probe during surgery.
Wang S; Yang W; Deng J; Zhang J; Ma F; Wang J
Nucl Med Commun; 2013 Mar; 34(3):249-53. PubMed ID: 23276828
[TBL] [Abstract][Full Text] [Related]
31. Different thallium-201 single-photon emission tomographic patterns in benign and aggressive meningiomas.
Tedeschi E; Soricelli A; Brunetti A; Romano M; Bucciero A; Iaconetta G; Alfieri A; Postiglione A; Salvatore M
Eur J Nucl Med; 1996 Nov; 23(11):1478-84. PubMed ID: 8854846
[TBL] [Abstract][Full Text] [Related]
32. Comparison of tc-99m depreotide and in-111 octreotide in recurrent meningioma.
Hellwig D; Samnick S; Reif J; Romeike BF; Reith W; Moringlane JR; Kirsch CM
Clin Nucl Med; 2002 Nov; 27(11):781-4. PubMed ID: 12394124
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of SPECT/CT with a hybrid camera for the functional anatomical mapping of primary brain tumors by [Tc99m] tetrofosmin.
Filippi L; Schillaci O; Santoni R; Manni C; Danieli R; Simonetti G
Cancer Biother Radiopharm; 2006 Feb; 21(1):41-8. PubMed ID: 16480330
[TBL] [Abstract][Full Text] [Related]
34. In vivo quantitation using SPECT of radiopharmaceutical uptake by human meningiomas.
Front D; Ioselevsky G; Frenkel A; Even-Sapir E; Israel O; Kolodny GM; Feinsud M
Radiology; 1987 Jul; 164(1):93-6. PubMed ID: 3035609
[TBL] [Abstract][Full Text] [Related]
35. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
36. The value of Tc-99m tetrofosmin in the imaging of pituitary adenomas.
Kurtulmus N; Turkmen C; Yarman S; Tokmak H; Mudun A
J Endocrinol Invest; 2007 Feb; 30(2):86-90. PubMed ID: 17392596
[TBL] [Abstract][Full Text] [Related]
37. Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma: technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography study.
Fukumoto M; Yoshida D; Hayase N; Kurohara A; Akagi N; Yoshida S
Cancer; 1999 Oct; 86(8):1470-9. PubMed ID: 10526275
[TBL] [Abstract][Full Text] [Related]
38. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
39. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
40. Detection of recurrent or residual nasopharyngeal carcinomas after radiotherapy with technetium-99m tetrofosmin single photon emission computed tomography and comparison with computed tomography--a preliminary study.
Tai CJ; Shiau YC; Wang JJ; Ho YJ; Ho ST; Kao CH
Cancer Invest; 2003; 21(4):536-41. PubMed ID: 14533443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
